[EN] SULFONAMIDE DERIVATIVES AS PPAR MODULATORS<br/>[FR] DERIVES DE SULFONAMIDES UTILISES COMME MODULATEURS DU RECEPTEUR PPAR
申请人:LILLY CO ELI
公开号:WO2004073606A2
公开(公告)日:2004-09-02
The present invention is directed to a compound of Formula (I):, and pharmaceutically acceptable salts, solvates, hydrates or stereoisomers thereof, which are useful in treating or preventing disorders mediated by a peroxisome proliferator activated receptor (PPAR) such as syndrome X, type II diabetes, hyperglycemia, hyperlipidemia, obesity, coagaulopathy, hypertension, arteriosclerosis, and other disorders related to syndrome X and cardiovascular diseases.